[1]
|
Ren, S., Zhang, X., Hu, Y., et al. (2020) Blocking the Notch Signal Transduction Pathway Promotes Tumor Growth in Osteosarcoma by Affecting Polarization of TAM to M2 Phenotype. Annals of Translational Medicine, 8, 1057.
https://doi.org/10.21037/atm-20-3881
|
[2]
|
Zhang, X., Bian, H., Wei, W., et al. (2021) DLX5 Promotes Osteosar-coma Progression via Activation of the NOTCH Signaling Pathway. American Journal of Cancer Research, 11, 3354-3374.
|
[3]
|
Yang, J. and Zhang, W. (2013) New Molecular Insights into Osteosarcoma Targeted Therapy. Current Opinion in Oncology, 25, 398-406. https://doi.org/10.1097/CCO.0b013e3283622c1b
|
[4]
|
Dana, P.M., Sadoughi, F., Asemi, Z., et al. (2022) Molecular Signaling Pathways as Potential Therapeutic Targets in Osteosarcoma. Current Medicinal Chemistry, 29, 4436-4444. https://doi.org/10.2174/0929867329666220209110009
|
[5]
|
Cui, J., Dean, D., Hornicek, F.J., et al. (2020) The Role of Extracelluar Matrix in Osteosarcoma Progression and Metastasis. Journal of Experimental & Clinical Cancer Research, 39, Article No. 178.
https://doi.org/10.1186/s13046-020-01685-w
|
[6]
|
Rojas, G.A., Hubbard, A.K., Diessner, B.J., et al. (2021) Inter-national Trends in Incidence of Osteosarcoma (1988-2012). International Journal of Cancer, 149, 1044-1053. https://doi.org/10.1002/ijc.33673
|
[7]
|
Banaszek, N., Kurpiewska, D., Kozak, K., et al. (2023) Hedgehog Pathway in Sarcoma: From Preclinical Mechanism to Clinical Application. Journal of Cancer Research and Clinical Oncology, 149, 17635-17649.
https://doi.org/10.1007/s00432-023-05441-3
|
[8]
|
Rothzerg, E., Erber, W.N., Gibbons, C.L.M.H., et al. (2023) Osteohematology: To Be or Notch to Be. Journal of Cellular Physiology, 238, 1478-1491. https://doi.org/10.1002/jcp.31042
|
[9]
|
Ji, Z., Shen, J., Lan, Y., et al. (2023) Targeting Signaling Pathways in Os-teosarcoma: Mechanisms and Clinical Studies. MedComm (2020), 4, e308. https://doi.org/10.1002/mco2.308
|
[10]
|
Menéndez, S.T., Gallego, B., Murillo, D., et al. (2021) Cancer Stem Cells as a Source of Drug Resistance in Bone Sarcomas. Journal of Clinical Medicine, 10, Article No. 2621. https://doi.org/10.3390/jcm10122621
|
[11]
|
Chen, S., Lee, B.H. and Bae, Y. (2014) Notch Signaling in Skeletal Stem Cells. Calcified Tissue International, 94, 68-77. https://doi.org/10.1007/s00223-013-9773-z
|
[12]
|
Nirala, B.K., Yamamichi, T. and Yustein, J.T. (2023) Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis. Inter-national Journal of Molecular Sciences, 24, Article No. 11367. https://doi.org/10.3390/ijms241411367
|
[13]
|
Zhang, J., Li, N., Lu, S., et al. (2021) The Role of Notch Ligand Jagged1 in Osteosarcoma Proliferation, Metastasis, and Recur-rence. Journal of Orthopaedic Surgery and Research, 16, Article No. 226.
|
[14]
|
Ongaro, A., Pellati, A., Bagheri, L., et al. (2016) Characterization of Notch Signaling during Osteogenic Differentiation in Human Osteosarcoma Cell Line MG63. Journal of Cellular Physiology, 231, 2652-2663.
https://doi.org/10.1002/jcp.25366
|
[15]
|
Farnood, P.R., Pazhooh, R.D., Asemi, Z., et al. (2022) Targeting Signaling Pathway by Curcumin in Osteosarcoma. Current Molecular Pharmacology, 16, 71-82.
|
[16]
|
Yu, L., Fan, Z., Fang, S., et al. (2016) Cisplatin Selects for Stem-Like Cells in Osteosarcoma by Activating Notch Signaling. Oncotarget, 7, 33055-33068. https://doi.org/10.18632/oncotarget.8849
|
[17]
|
Lu, K.H., Lu, P.W., Lu, E.W., et al. (2023) Curcumin and Its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma. International Journal of Bio-logical Sciences, 19, 1241-1265.
https://doi.org/10.7150/ijbs.80590
|
[18]
|
Hijioka, H., Setoguchi, T., Miyawaki, A., et al. (2010) Upregulation of Notch Pathway Molecules in Oral Squamous Cell Carcinoma. International Journal of Oncology, 36, 817-822. https://doi.org/10.3892/ijo_00000558
|
[19]
|
Zhang, H., Chen, G., Lyu, X., et al. (2021) A Novel Predictive Model Associated with Osteosarcoma Metastasis. Cancer Management and Research, 13, 8411-8423. https://doi.org/10.2147/CMAR.S332387
|
[20]
|
Meurette, O. and Mehlen, P. (2018) Notch Signaling in the Tumor Microenvironment. Cancer Cell, 34, 536-548.
https://doi.org/10.1016/j.ccell.2018.07.009
|
[21]
|
Tang, X.F., Cao, Y., Peng, D.B., et al. (2019) Overexpression of Notch3 Is Associated with Metastasis and Poor Prognosis in Osteosarcoma Patients. Cancer Management and Research, 11, 547-559.
https://doi.org/10.2147/CMAR.S185495
|
[22]
|
Xu, N., Wang, X., Wang, L., et al. (2022) Comprehensive Analysis of Potential Cellular Communication Networks in Advanced Osteosarcoma Using Single-Cell RNA Sequencing Data. Frontiers in Genetics, 13, Article ID: 1013737.
https://doi.org/10.3389/fgene.2022.1013737
|
[23]
|
Bae, Y., Zeng, H.C., Chen, Y.T., et al. (2022) MiRNA-34c Sup-presses Osteosarcoma Progression in Vivo by Targeting Notch and E2F. JBMR Plus, 6, e10623. https://doi.org/10.1002/jbm4.10623
|
[24]
|
Yan, K., Gao, J., Yang, T., et al. (2012) MicroRNA-34a Inhibits the Pro-liferation and Metastasis of Osteosarcoma Cells both in Vitro and in Vivo. PLOS ONE, 7, e33778. https://doi.org/10.1371/journal.pone.0033778
|
[25]
|
Pu, Y., Zhao, F., Wang, H., et al. (2017) MiR-34a-5p Promotes Multi-Chemoresistance of Osteosarcoma through Down-Regulation of the DLL1 Gene. Scientific Reports, 7, Article No. 44218. https://doi.org/10.1038/srep44218
|
[26]
|
Li, C., Guo, D., Tang, B., et al. (2016) Notch1 Is Associated with the Multidrug Resistance of Hypoxic Osteosarcoma by Regulating MRP1 Gene Expression. Neoplasma, 63, 734-742. https://doi.org/10.4149/neo_2016_510
|
[27]
|
Tian, Q., Jia, J., Ling, S., et al. (2014) A Causal Role for Circulating MiR-34b in Osteosarcoma. European Journal of Surgical Oncology, 40, 67-72. https://doi.org/10.1016/j.ejso.2013.08.024
|
[28]
|
Pan, B.L., Wu, L., Pan, L., et al. (2018) Up-Regulation of Mi-croRNA-340 Promotes Osteosarcoma Cell Apoptosis While Suppressing Proliferation, Migration, and Invasion by Inac-tivating the CTNNB1-Mediated Notch Signaling Pathway. BioScientific Reports, 38, BSR20171615. https://doi.org/10.1042/BSR20171615
|
[29]
|
Wang, L., Hu, K., Chao, Y., et al. (2020) MicroRNA-1296-5p Sup-presses the Proliferation, Migration, and Invasion of Human Osteosarcoma Cells by Targeting NOTCH2. Journal of Cellular Biochemistry, 121, 2038-2046.
https://doi.org/10.1002/jcb.29438
|
[30]
|
Lu, J., Song, G., Tang, Q., et al. (2017) MiR-26a Inhibits Stem Cell-Like Phenotype and Tumor Growth of Osteosarcoma by Targeting Jagged1. Oncogene, 36, 231-241. https://doi.org/10.1038/onc.2016.194
|
[31]
|
Cai, W.T., Guan, P., Lin, M.X., et al. (2020) MiRNA-206 Suppresses the Metastasis of Osteosarcoma via Targeting Notch3. Journal of Biological Regulators and Homeostatic Agents, 34, 775-783.
|
[32]
|
Won, K.Y., Kim, Y.W., Kim, H.S., et al. (2013) MicroRNA-199b-5p Is Involved in the Notch Signaling Pathway in Osteosarcoma. Human Pathology, 44, 1648-1655. https://doi.org/10.1016/j.humpath.2013.01.016
|
[33]
|
Zeng, H., Zhang, Z., Dai, X., et al. (2016) Increased Expres-sion of MicroRNA-199b-5p Associates with Poor Prognosis through Promoting Cell Proliferation, Invasion and Migra-tion Abilities of Human Osteosarcoma. Pathology and Oncology Research, 22, 253-260. https://doi.org/10.1007/s12253-015-9901-3
|
[34]
|
Han, J. and Shen, X. (2020) Long Noncoding RNAs in Osteo-sarcoma via Various Signaling Pathways. Journal of Clinical Laboratory Analysis, 34, e23317. https://doi.org/10.1002/jcla.23317
|
[35]
|
Kushlinskii, N.E., Fridman, M.V. and Braga, E.A. (2020) Long Non-Coding RNAs as Competitive Endogenous RNAs in Osteosarcoma]. Molecular Biology (Mosk), 54, 776-801. https://doi.org/10.1134/S0026893320050052
|
[36]
|
Chen, L., Wang, J., Li, J.W., et al. (2020) LncRNA MEG3 In-hibits Proliferation and Promotes Apoptosis of Osteosarcoma Cells through Regulating Notch Signaling Pathway. Euro-pean Review for Medical and Pharmacological Sciences, 24, 581-590.
|
[37]
|
Xia, P., Gu, R., Zhang, W., et al. (2020) LncRNA CEBPA-AS1 Overexpression Inhibits Proliferation and Migration and Stimulates Apoptosis of OS Cells via Notch Signaling. Molecular Therapy—Nucleic Acids, 19, 1470-1481.
https://doi.org/10.1016/j.omtn.2019.10.017
|
[38]
|
Zhou, S., Yu, L., Xiong, M., et al. (2018) LncRNA SNHG12 Promotes Tumorigenesis and Metastasis in Osteosarcoma by Upregulating Notch2 by Sponging MiR-195-5p. Biochem-ical and Biophysical Research Communications, 495, 1822-1832. https://doi.org/10.1016/j.bbrc.2017.12.047
|
[39]
|
Ghafouri-Fard, S., Khoshbakht, T., Bahranian, A., et al. (2021) CircMTO1: A Circular RNA with Roles in the Carcinogenesis. Biomedicine & Pharmacotherapy, 142, Article ID: 112025. https://doi.org/10.1016/j.biopha.2021.112025
|
[40]
|
Gong, G., Han, Z., Wang, W., et al. (2020) Silencing Hsa_CircRNA_0008035 Exerted Repressive Function on Osteosarcoma Cell Growth and Migration by Upregulating MicroRNA-375. Cell Cycle, 19, 2139-2147.
https://doi.org/10.1080/15384101.2020.1792636
|
[41]
|
Dai, G., Deng, S., Guo, W., et al. (2019) Notch Pathway In-hibition Using DAPT, a γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Cisplatin in Resistant Osteosar-coma. Molecular Carcinogenesis, 58, 3-18.
https://doi.org/10.1002/mc.22873
|
[42]
|
Qin, J., Wang, R., Zhao, C., et al. (2019) Notch Signaling Regulates Osteo-sarcoma Proliferation and Migration through Erk Phosphorylation. Tissue Cell, 59, 51-61. https://doi.org/10.1016/j.tice.2019.07.002
|
[43]
|
Belayneh, R. and Weiss, K. (2020) The Role of ALDH in the Meta-static Potential of Osteosarcoma Cells and Potential ALDH Targets. Advances in Experimental Medicine and Biology, 1258, 157-166.
https://doi.org/10.1007/978-3-030-43085-6_10
|
[44]
|
Dai, G., Liu, G., Zheng, D., et al. (2021) Inhibition of the Notch Signaling Pathway Attenuates Progression of Cell Motility, Metastasis, and Epithelial-to-Mesenchymal Transi-tion-Like Phenomena Induced by Low Concentrations of Cisplatin in Osteosarcoma. European Journal of Pharmacology, 899, Article ID: 174058.
https://doi.org/10.1016/j.ejphar.2021.174058
|